This study, published in the National Library of Medicine, addresses the role of Real-World Evidence (RWE) in building an evidence base around medicinal cannabis.

Whilst access to cannabis-based medicinal products (CBMPs) has increased globally subject to relaxation of scheduling laws globally, one of the main barriers to appropriate patient access remains a paucity of high-quality evidence surrounding their clinical efect.